2020-12-30 - The Riese Lab has published a report in PLOS One that describes the development and deployment of a high-throughput screen for candidate ERBB4 antagonists. The lead authors of this work are Richard Cullum and Lauren Lucas. Congratulations to Richard, Lauren, and the rest of the team! Link to publication. Pubmed entry.
2020-12-03 - David Riese has collaborated with Jianzhong Shen's laboratory on a review article in Frontiers in Pharmacology on the role of the chemokine CXCL12/CXCR4/CXCR7 axis in cancer. Congratulations to graduate student Yi Shi of the Shen lab for her outstanding contributions to this work. Link to publication. Pubmed entry.
2020-12-01 - David Riese has been appointed to an affiliate faculty position at the O'Neal Comprehensive Cancer Center at the University of Alabama-Birmingham. David is affiliated with the Cancer Biology and Immunology Research Program. Congratulations, David!
2020-09-30 - Former Riese lab graduate student Richard Cullum has been named as one of 6 recipients of the 2020 Auburn University Graduate School Distinguished Dissertation Awards. This award is based on the significance of Richard's dissertation research and its methodological and substantive quality. Congratulations, Richard!
2020-08-01 - Dr. Vipasha Dwivedi has joined the Riese laboratory as an unpaid, part-time graduate student. Vipasha earned an MBBS from NIMS University in India. She completed internship and residency training in India, afterwhich she practiced at the Nav Bharti Industrial Training Institute in India. Welcome, Vipasha!
2020-05-06 - Riese lab graduate student Richard Cullum has been awarded the PhD in Chemical Engineering from Auburn University. Richard's doctoral dissertation is entitled "Melanoma drug discovery: Prioritization of candidate melanoma driver mutations in the ERBB4 receptor tyrosine kinase gene and identification of novel molecules that disrupt ERBB4 signaling." Congratulations, Richard!
2020-04-16 - The Auburn University Office of the Vice President for Research and Economic Development has funded a grant application from the Riese laboratory. The application, entitled "Targeted Melanoma Therapy: Identification of ERBB4 Melanoma Driver Mutants", is focused on the identification of actionable biomarkers in drug-resistant, BRAF-wild type melanomas.
2020-04-07 - Riese lab graduate student Richard Cullum has been recognized for his efforts in developing the first commercially-available COVID-19 test available in the State of Alabama. This work, done at Assurance Scientific Labs, leverages Richard's training in assay design and validation at Auburn University. Congratulations, Richard!